HK Stock MarketDetailed Quotes

01801 INNOVENT BIO

Watchlist
  • 39.150
  • -0.200-0.51%
Not Open Nov 28 16:08 CST
64.12BMarket Cap-45682P/E (TTM)

INNOVENT BIO Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
Turnover
46.30%3.95B
36.21%6.21B
20.63%2.7B
6.71%4.56B
15.34%2.24B
11.08%4.27B
97.29%1.94B
266.94%3.84B
184.85%984.21M
10,953.34%1.05B
Operating income
46.30%3.95B
36.21%6.21B
20.63%2.7B
6.71%4.56B
15.34%2.24B
11.08%4.27B
97.29%1.94B
266.94%3.84B
184.85%984.21M
10,953.34%1.05B
Cost of sales
-34.27%-677.55M
-22.05%-1.14B
-7.02%-504.62M
-84.23%-930.99M
-117.42%-471.53M
-30.32%-505.34M
-17.35%-216.88M
-210.51%-387.76M
-351.30%-184.82M
---124.88M
Operating expenses
-34.27%-677.55M
-22.05%-1.14B
-7.02%-504.62M
-84.23%-930.99M
-117.42%-471.53M
-30.32%-505.34M
-17.35%-216.88M
-210.51%-387.76M
-351.30%-184.82M
-124.88M
Gross profit
49.06%3.27B
39.84%5.07B
24.26%2.2B
-3.69%3.63B
2.50%1.77B
8.92%3.76B
115.77%1.72B
274.58%3.46B
162.47%799.39M
9,635.64%922.65M
Selling expenses
-39.48%-1.88B
-19.68%-3.1B
3.61%-1.35B
1.12%-2.59B
-28.93%-1.4B
-95.41%-2.62B
-142.76%-1.08B
-12.47%-1.34B
-67.45%-446.62M
-776.61%-1.19B
Administrative expenses
13.19%-319.8M
10.20%-750.28M
9.66%-368.39M
-3.66%-835.49M
-32.46%-407.8M
-84.50%-806.01M
-64.78%-307.87M
-71.12%-436.87M
-139.19%-186.84M
-15.88%-255.3M
Research and development expenses
-51.65%-1.4B
22.42%-2.23B
21.43%-922.82M
-23.63%-2.87B
-20.54%-1.17B
-25.44%-2.32B
-20.59%-974.32M
-43.00%-1.85B
-20.46%-807.95M
-5.98%-1.29B
Special items of operating profit
-113.02%-30.72M
-106.14%-37.06M
-8.48%235.89M
201.40%603.31M
176.99%257.73M
3.61%-594.98M
-578.42%-334.75M
-487.82%-617.24M
110.16%69.97M
103.76%159.16M
Operating profit
-72.27%-354.57M
49.45%-1.05B
78.43%-205.82M
19.79%-2.07B
2.25%-954.35M
-226.34%-2.58B
-70.67%-976.3M
52.40%-790.36M
15.59%-572.05M
71.39%-1.66B
Financing cost
24.40%-38.02M
3.02%-98.62M
-12.85%-50.29M
-62.81%-101.7M
-64.43%-44.57M
8.61%-62.46M
16.89%-27.1M
-14.89%-68.35M
11.22%-32.61M
13.74%-59.49M
Earning before tax
-53.29%-392.59M
47.27%-1.14B
74.36%-256.11M
17.84%-2.17B
0.45%-998.91M
-207.64%-2.64B
-65.94%-1B
50.07%-858.71M
15.36%-604.67M
70.71%-1.72B
Tax
-100.03%-35K
1,423.69%116.5M
141.43%116.96M
89.89%-8.8M
31,971.05%48.44M
37.70%-87.04M
95.69%-152K
---139.71M
---3.53M
----
After-tax profit from continuing operations
-182.16%-392.62M
52.83%-1.03B
85.36%-139.15M
20.14%-2.18B
5.29%-950.47M
-173.31%-2.73B
-65.01%-1B
41.95%-998.42M
14.87%-608.19M
70.71%-1.72B
Earning after tax
-182.16%-392.62M
52.83%-1.03B
85.36%-139.15M
20.14%-2.18B
5.29%-950.47M
-173.31%-2.73B
-65.01%-1B
41.95%-998.42M
14.87%-608.19M
70.71%-1.72B
Profit attributable to shareholders
-182.16%-392.62M
52.83%-1.03B
85.36%-139.15M
20.14%-2.18B
5.29%-950.47M
-173.31%-2.73B
-65.01%-1B
41.95%-998.42M
14.87%-608.19M
70.20%-1.72B
Basic earnings per share
-166.67%-0.24
54.79%-0.66
86.15%-0.09
22.34%-1.46
5.80%-0.65
-154.05%-1.88
-50.00%-0.69
49.32%-0.74
25.81%-0.46
91.53%-1.46
Diluted earnings per share
-166.67%-0.24
54.79%-0.66
86.15%-0.09
22.34%-1.46
5.80%-0.65
-154.05%-1.88
-50.00%-0.69
49.32%-0.74
25.81%-0.46
91.53%-1.46
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019
Turnover 46.30%3.95B36.21%6.21B20.63%2.7B6.71%4.56B15.34%2.24B11.08%4.27B97.29%1.94B266.94%3.84B184.85%984.21M10,953.34%1.05B
Operating income 46.30%3.95B36.21%6.21B20.63%2.7B6.71%4.56B15.34%2.24B11.08%4.27B97.29%1.94B266.94%3.84B184.85%984.21M10,953.34%1.05B
Cost of sales -34.27%-677.55M-22.05%-1.14B-7.02%-504.62M-84.23%-930.99M-117.42%-471.53M-30.32%-505.34M-17.35%-216.88M-210.51%-387.76M-351.30%-184.82M---124.88M
Operating expenses -34.27%-677.55M-22.05%-1.14B-7.02%-504.62M-84.23%-930.99M-117.42%-471.53M-30.32%-505.34M-17.35%-216.88M-210.51%-387.76M-351.30%-184.82M-124.88M
Gross profit 49.06%3.27B39.84%5.07B24.26%2.2B-3.69%3.63B2.50%1.77B8.92%3.76B115.77%1.72B274.58%3.46B162.47%799.39M9,635.64%922.65M
Selling expenses -39.48%-1.88B-19.68%-3.1B3.61%-1.35B1.12%-2.59B-28.93%-1.4B-95.41%-2.62B-142.76%-1.08B-12.47%-1.34B-67.45%-446.62M-776.61%-1.19B
Administrative expenses 13.19%-319.8M10.20%-750.28M9.66%-368.39M-3.66%-835.49M-32.46%-407.8M-84.50%-806.01M-64.78%-307.87M-71.12%-436.87M-139.19%-186.84M-15.88%-255.3M
Research and development expenses -51.65%-1.4B22.42%-2.23B21.43%-922.82M-23.63%-2.87B-20.54%-1.17B-25.44%-2.32B-20.59%-974.32M-43.00%-1.85B-20.46%-807.95M-5.98%-1.29B
Special items of operating profit -113.02%-30.72M-106.14%-37.06M-8.48%235.89M201.40%603.31M176.99%257.73M3.61%-594.98M-578.42%-334.75M-487.82%-617.24M110.16%69.97M103.76%159.16M
Operating profit -72.27%-354.57M49.45%-1.05B78.43%-205.82M19.79%-2.07B2.25%-954.35M-226.34%-2.58B-70.67%-976.3M52.40%-790.36M15.59%-572.05M71.39%-1.66B
Financing cost 24.40%-38.02M3.02%-98.62M-12.85%-50.29M-62.81%-101.7M-64.43%-44.57M8.61%-62.46M16.89%-27.1M-14.89%-68.35M11.22%-32.61M13.74%-59.49M
Earning before tax -53.29%-392.59M47.27%-1.14B74.36%-256.11M17.84%-2.17B0.45%-998.91M-207.64%-2.64B-65.94%-1B50.07%-858.71M15.36%-604.67M70.71%-1.72B
Tax -100.03%-35K1,423.69%116.5M141.43%116.96M89.89%-8.8M31,971.05%48.44M37.70%-87.04M95.69%-152K---139.71M---3.53M----
After-tax profit from continuing operations -182.16%-392.62M52.83%-1.03B85.36%-139.15M20.14%-2.18B5.29%-950.47M-173.31%-2.73B-65.01%-1B41.95%-998.42M14.87%-608.19M70.71%-1.72B
Earning after tax -182.16%-392.62M52.83%-1.03B85.36%-139.15M20.14%-2.18B5.29%-950.47M-173.31%-2.73B-65.01%-1B41.95%-998.42M14.87%-608.19M70.71%-1.72B
Profit attributable to shareholders -182.16%-392.62M52.83%-1.03B85.36%-139.15M20.14%-2.18B5.29%-950.47M-173.31%-2.73B-65.01%-1B41.95%-998.42M14.87%-608.19M70.20%-1.72B
Basic earnings per share -166.67%-0.2454.79%-0.6686.15%-0.0922.34%-1.465.80%-0.65-154.05%-1.88-50.00%-0.6949.32%-0.7425.81%-0.4691.53%-1.46
Diluted earnings per share -166.67%-0.2454.79%-0.6686.15%-0.0922.34%-1.465.80%-0.65-154.05%-1.88-50.00%-0.6949.32%-0.7425.81%-0.4691.53%-1.46
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --Deloitte Guan Huang Chen Fang Certified Public Accountants--Deloitte Guan Huang Chen Fang Certified Public Accountants--Deloitte Guan Huang Chen Fang Certified Public Accountants--Deloitte Guan Huang Chen Fang Certified Public Accountants--Deloitte Guan Huang Chen Fang Certified Public Accountants

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data